XIPERE
Clearside Biomedical, Inc.
Application Filed: 2018-04-27
Trademark Application Details
FIRST EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87896124 |
| Registration Number | 6672372 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Bassam N. Ibrahim |
| Attorney Docket Number | 0080003-102 |
| Law Office Assigned | M40 |
| Employee Name | BILLINGS, JOHN T |
Timeline
| 2018-04-27 | Application Filed |
| 2018-09-25 | Published for Opposition |
| 2019-03-19 | Location: INTENT TO USE SECTION |
| 2019-08-16 | Status: Live/Pending |
| 2019-08-20 | Transaction Date |
| 2022-03-15 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Clearside Biomedical, Inc. |
| Address | 1220 Old Alpharetta Rd., Suite 300 Alpharetta DE 30005 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | Ocular pharmaceuticals; Ophthalmic preparations |
| GS0051 | Ocular pharmaceuticals; ophthalmic preparations |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-05-01 | 1 NWAP I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2018-05-02 | 2 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2018-05-02 | 3 CHAN I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-05-05 | 4 NWOS I:Incoming Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2018-06-21 | 5 PARI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2018-07-11 | 6 ALIE A:Allowance for Publication |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2018-07-11 | 7 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2018-08-17 | 8 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-08-21 | 9 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-09-05 | 10 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-09-25 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-09-25 | 12 NPUB E:E-Mail |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2018-10-25 | 13 ETOF T:TTAB Proceeding |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2019-02-03 | 14 ETOP T:TTAB Proceeding |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-03-19 | 15 NOAM E:E-Mail |
| ASSIGNED TO EXAMINER | 2019-07-08 | 16 DOCK D:Assigned to Examiner |
| TEAS EXTENSION RECEIVED | 2019-08-16 | 17 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2019-08-16 | 18 EXT1 S: |
| EXTENSION 1 GRANTED | 2019-08-16 | 19 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-08-20 | 20 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-03-03 | 21 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2020-03-03 | 22 EXT2 S: |
| EXTENSION 2 GRANTED | 2020-03-03 | 23 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-03-05 | 24 EXRA E:E-Mail |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-08-12 | 25 ASCK I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-08-12 | 26 ASCK I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2020-09-16 | 27 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2020-09-16 | 28 EXT3 S: |
| EXTENSION 3 GRANTED | 2020-09-16 | 29 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-09-18 | 30 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-01-25 | 31 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2021-01-25 | 32 EXT4 S: |
| EXTENSION 4 GRANTED | 2021-01-25 | 33 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-01-27 | 34 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-09-07 | 35 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-09-14 | 36 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2021-09-07 | 37 EXT5 S: |
| EXTENSION 5 GRANTED | 2021-09-16 | 38 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-09-17 | 39 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2022-01-06 | 40 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2022-01-06 | 41 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2022-01-08 | 42 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2022-02-08 | 43 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-02-09 | 44 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-03-15 | 45 R.PR A:Allowance for Publication |
| TEAS SECTION 7 REQUEST RECEIVED | 2022-04-01 | 46 ES7R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-08-31 | 47 APRE A:Allowance for Publication |
| CORRECTION UNDER SECTION 7 ¿ PROCESSED | 2022-09-03 | 48 COC. O:Outgoing Correspondence |
| REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD | 2022-09-03 | 49 CORV 6: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 XIPERE 88221046 not registered Live/Pending |
Clearside Biomedical, Inc. 2018-12-07 |
 XIPERE 87896124 not registered Live/Pending |
Clearside Biomedical, Inc. 2018-04-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 